Multiple sclerosis: Current and future treatment options

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 7, Issue 4, 2007, Pages 292-299

  Rizvi, S ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Antibodies; Degeneration; Demyelination; Immunosupression; Interferon; MRI; Multiple sclerosis; Relapses; Trials

Indexed keywords

ALEMTUZUMAB; ALPHA INTERFERON; AZATHIOPRINE; BETA1A INTERFERON; CLADRIBINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACLIZUMAB; FINGOLIMOD; FIRATEGRAST; FUMARIC ACID DIMETHYL ESTER; GAMMA INTERFERON; GLATIRAMER; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERFERON; INTERFERON BETA SERINE; LENERCEPT; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; MONOCLONAL ANTIBODY; MYELIN; NATALIZUMAB; PLACEBO; RITUXIMAB; ROQUINIMEX; TERIFLUNOMIDE; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; BLADDER CANCER; CARDIOMYOPATHY; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DEMYELINATION; DEPRESSION; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; DOSE RESPONSE; DRUG ACTIVITY; DRUG APPROVAL; DRUG DOSE COMPARISON; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FLU LIKE SYNDROME; GINGIVITIS; GOODPASTURE SYNDROME; GRANULOMA; GRAVES DISEASE; HEMORRHAGIC CYSTITIS; HERPES SIMPLEX; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPATHOLOGY; INFECTION; INJECTION SITE REACTION; LEUKEMIA; LIVER DYSFUNCTION; LUNG TOXICITY; MEASLES; MEMORY DISORDER; MONOTHERAPY; MOOD DISORDER; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOSIS; RELAPSE; REMISSION; REPEATED DRUG DOSE; REVIEW; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VASCULAR NECROSIS;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; MULTIPLE SCLEROSIS;

EID: 37549045644     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153007782794380     Document Type: Review

References (101)

1. Steinman, L. (2001) Nat Immunol., 2(9), 762-764.
2. Grigoriadis, N.; Grigoriadis, S.; Polyzoidou, E.; Milonas, I. and Karussis, D. (2006) Clin. Neurol. Neurosurg., 108(3), 241-244.
3. Martino, G.; Furlan, R.; Brambilla, E.; Birgami, A., Ruffini, F.; Geroni, M.; Poliani, P.L.; Grimaldi L.M. and Comi, G. (2000) J. Neuroimmunol., 109, 3-9
4. Duddy, M. and Bar-Or, A. (2006) Int. MS J., 13(3), 84-90.
5. Lucchinetti, C.; Bruck, W.; Parisi, J.; Scheithauer, B.; Rodriguez, M. and Lassmann, H. (2000) Ann. Neurol., 47, 707-717.
6. Neumann, H. (2003) Curr. Opin. Neurol., 16, 267-273.
7. Kuhlmann, T.; Lingfeld, G.; Bitsch, A.; Schuchardt, J. and Bruck, W. (2002) Brain, 125, 2202-2212.
8. Bruck, W. (2005) J. Neurol., 252 Suppl 5, 3-9. Review.
9. Smith, K.J. (2006) Rev. Prat., 56(12), 1299-1303.
10. Dhib-Jalbut, S. (1997) Mult. Scler., 3, 397-401.
11. IFNB Multiple sclerosis study Group, (1993) Neurology, 43, 655-661.
12. Zhao, G.J.; Koopmans RA.; Li, D.K.B.; Bedell, L. and Paty, D.W. (2000) Neurology, 54(1), 200-206.
13. Jacobs, L.D.; Cookfair, D.L.; Rudick, R.A. and The Multiple Sclerosis Collaborative research Group (1996) Ann. Neurol., 39(3), 285-294.
14. Simon, J.H.; Jacobs, L.D.; Campion, M. and The Multiple Sclerosis Collaborative Research Group (1998) Ann. Neurol., 43(1), 79-87.
15. Rudick, R.A.; Fisher, E.; Lee, J-C. and The Multiple Sclerosis research Collaborative Group (1999) Neurology, 53(8), 1698-1704.
16. PRISMS Study Group (1998) Lancet, 352, 1498-1504.
17. The PRISMS Study Group and the University of British Columbia MS/MRI Analysis Group (2001) Neurology, 56, 1628-1636.
18. Kappos, L.; Traboulsee, A.; Constantinescu, C.; Eralinna, J.P.; Forrestal, F.; Jongen, P.; Pollard, J.; Sandberg-Wollheim, M.; Sindic, C.; Stubinski, B.; Uitdehaag, B. and Li, D. (2006) Neurology, 67(6), 944-953.
19. Jacobs, L.D.; Beck, R.W.; Simon, J.H. and the Controlled High Risk Subjects AVONEX® Multiple Sclerosis Prevention Study (CHAMPS) Group.(2000) N. Engl. J. Med., 343(13), 898-904.
20. CHAMPIONS Study Group (2006) Neurology, 66, 678-684.
21. Comi, G.; Filippi, M.; Barkhof, F.; Durelli, L.; Edan, G.; Fernandez, O.; Hartung, H.; Seeldrayers, P.; Sorensen, P.S.; Rovaris, M.; Martinelli, V.; Hommes, O.R. and The Early Treatment of multiple Sclerosis Study Group (2001) Lancet, 357, 1576-1582.
22. Kappos, L.; Polman, C.H.; Freedman, M.S.; Edan, G.; Hartung, H.P.; Miller, D.H.; Montalban, X.; Barkhof, F.; Bauer, L.; Jakobs, P.; Pohl, C. and Sandbrink, R. for the BENEFIT Study Group (2006) Neurology, 67(7), 1242-1249.
23. OWIMS (Once Weekly Interferon for MS) Study Group (1999) Neurology, 53, 679-686.
24. Panitch, H.; Goodin, D.S.; Francis, G.; Chang, P.; Coyle, P.K.; O'Connor, P.; Monaghan, E.; Li, D. and Weinshenker, B. (2002) Neurology, 59(10), 1496-1506.
25. Durelli, L.; Verdun, E.; Barbero, P.; Bergui, M.; Versino, E.; Ghezzi, A.; Montanari, E. and Zaffaroni, M. (2002) Lancet, 359(9316), 1453-1460
26. Sorensen, P.S.; Ross, C.; Clemmesen, K.M.; Bendtzen, K.; Frederiksen, J.L.; Jensen, K.; Kristensen, O.; Petersen, T.; Rasmussen, S.; Ravnborg, M.; Stenager, E. and Koch-Henriksen, N. (2003) Lancet, 362(9391), 1184-1191.
27. Koch-Henriksen, N.; Sorensen, P.S.; Christensen; Frederiksen, J.; Ravnborg, M.; Jensen, K.; Heltherg, A.; Kristensen, O.; Stenager, E.; Petersen, T. and Hansen, T. for the Danish Multiple Sclerosis Group (2066) Neurology, 66(7), 1056-1060.
28. Cook, S.D. (2003) J. Neurol., 250(suppl 4), IV15-20.
29. European Study Group on interferon beta-1b in secondary progressive MS (1998) Lancet, 352, 1491-1497.
30. The North American Study Group on Interferon beta-1b in Secondary Progressive MS (2004) Neurology, 4(63), 1788-1795.
31. Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group (2001) Neurology, 56, 1496-1504.
32. Cohen, J.A.; Cutter, G.R.; Fischer, J.S.; Goodman, A.D.; Heidenreich, F.R.; Kooijmans, M.F.; Sandrock, A.W.; Rudick, R.A.; Simon, J.H.; Simoman, N.A.; Tsoa, E.C. and Whitaker, N.J. (2002) Neurology, 59, 679-687.
33. Neuhaus, O.; Farina, C.; Wekerle, H. and Hohlfeld, R. (2001) Neurology, 56, 702-708.
34. Chen, M.; Gran, B.; Costell, K.; Johnson, K.; Martin, R. and Dhib-Jalbut, S. (2001) Mult. Scler., 7(4), 209-219.
35. Ziemssen, T.; Kumpfel, T.; Klinkert, W.E.F.; Neuhaus, O. and Hohlfeld, R. (2002) Brain, 125(Pt 11), 2381-2391.
36. Azoulay, D.; Vachapova, V.; Shihman, B.; Miler, A. and Karni, A. (2005) J. Neuroimmunol., 167(1-2), 215-218.
37. Johnson, K.P.; Brooks, B.R.; Cohen, J.A.; Ford, C.C.; Goldstein, J.; Lisak, R.P.; Myers, L.W.; Panitch, H.S. and Rose, J.W.(1995) Neurology, 45(7), 1268-1276.
38. Ford, C.C.; Johnson, K.P.; Lisak, R.P.; Panitch, H.S.; Shifronis, G.; Wolinsky, J.S. and The Copaxone Study Group (2006) Mult. Scler., 12(3), 309-320.
39. Yong, V.W. (2002) Neurology, 59(6), 802-808.
40. Comi, G.; Filippi, M.; Wolinsky, J.S. end the European/Canadian GA study group. (2001) Ann. Neurol., 49, 290-297.
41. Filippi, M.; Rovaris, M.; Rocca, M.A.; Sormani, M.P.; Wolinsky, J.S.; Comi, G. and Eurpoean/Canadian Glatiramer Acetate Study Group (2001) Neurology, 57(4), 731-733.
42. Wolinsky, J.S. (2004) Mult. Scler., 10 (Suppl. 1), S65-72.
43. Tubridy, N.; Behan, P.O.; Capildeo, R.; Chaudhuri, A.; Forbes, R.; Hawkins, C.P.; Hughes, R.A.; Palace, J.; Sharrack, B.; Swingler, R.; Young, C.; Moseley, I.F.; MacManus, D.G.; Donoghue, S.; Miller, D.H. and The UK Antegren Study Group (1999) Neurology, 53(3), 466-472.
44. Frenette, P.S. and Wagner, D.D. (1996) N. Engl. J. Med., 334(23), 1526-1529.
45. Frenette, P.S. and Wagner, D.D. (1996) N. Engl. J. Med., 335(1), 43-45.
46. Miller, D.H.; Khan, O.A.; Sheremata, W.A.; Blumhardt, L.D.; Rice, G.P.; Libonati, M.A.; Willmer-Hulme, A.J.; Dalton, C.M.; Miszkiel, K.A.; O'Connor, P.W. and International Natalizumab Multiple Sclerosis Trial Group (2003) N. Engl. J. Med., 348(1), 15-23.
47. Polman, C.H.; O'Connor, P.W.; Havrdova, E.; Hutchinson, M.; Kappos, L.; Miller, D.H.; Phillips, J.T.; Lublin, F.D.; Giovannoni, G.; Wajgt, A.; Toal, M.; Lynn, F.; Panzara, M.A.; Sandrock, A.W. and AFFIRM Investigators (2006) N. Engl. J. Med., 354(9), 899-910.
48. Rudick, R.A.; Stuart, W.H.; Calabresi, P.A.; Confavreux, C.; Galetta, S.L.; Radue, E.W.; Lublin, F.D.; Weinstock-Guttman, B.; Wynn, D.R.; Lynn, F.; Panzara, M.A.; Sandrock, A.W. and SENTINEL Investigators (2006) N. Engl. J. Med., 354(9), 911-923.
49. Yousry, T.A.; Major, E.O.; Ryschkewitsch, C.; Fahle, G.; Fischer, S.; Hou, J.; Curfman, B.; Miszkiel, K.; Mueller-Lenke, N.; Sanchez, E.; Barkhof F.; Radue, E.W.; Jager, H.R. and Clifford, D.B. (2006) N. Engl. J. Med., 354(9), 924-933.
50. Moreau, T.; Coles, A.; Wing, M.; Thorpe, J.; Moseley, L; Issacs, J.; Hale, G.; Clayton, D.; Scolding, N.; Waldmann, H. and Compston, A. (1996) Mult. Scler., 1(6), 357-365.
51. Coles, A.J.; Wing, M.G.; Molyneux, P.; Paolillo, A.; Davie, C.M.; Hale, G.; Miller, D.; Waldmann, H. and Compston, A. (1999) Ann. Neurol., 46, 296-304.
52. Paolillo, A.; Coles, A.J.; Molyneux, P.D.; Gawne-Cain, M.; MacManus, D.; Barker, G.J.; Compston, D.A. and Miller, D.H. (1999) Neurology, 53(4), 751-757.
53. Coles, A.; Dean, J. and Compston, A. (2004) Clin. Neurol. Neurosurg., 106(3), 270-274
54. Coles, A.J.; Wing, M.; Smith, S.; Corradu, F.; Greer, S.; Taylor, C.; Wheetman, A.; Hale, G.; Chaterjee, V.K.; Waldniiiiii, H. and Compston, A. (1999) Lancet, 354(9191), 1691-1695.
55. Rastetter, W.; Molina, A. and White, C.A. (2004) Annu. Rev. Med., 55, 477-503.
56. Cree, B.A.C.; Lamb, S.; Morgan, K.; Chen, A.; Waubant, E. and Genain, C. (2005) Neurology, 64(7) 1270-1272.
57. Bielekova, B.; Richert, N.; Howard, T.; Blevins, G.; Markovicplese, S.; McCartin, J.; Frank, J.A.; Wurfel, J.; Ohayon, J.; Waldmann, T.A.; McFarland, H.F. and Martin, R. (2004) Proc. Natl. Acad. Sci. USA, 101, 8705-8708.
58. Rose, J.W.; Watt, H.E.; White, A.T. and Carlson, N.G. (2004) Ann. Neurol., 56(6), 864-867.
59. Noseworthy, J.H.; Hopkins, M.B.; Vandervoort M.K.; Karlik, S.J.; Lee, D.H.; Penman, M.; Rice, G.P.; Grinwich, K.D.; Cauvier, H.; Harris, B.J. and Ebers, G.C. (1993) Neurology, 43(7), 1401-1406.
60. Mauch, E.; Kornhuber, H.H.; Krapf, H.; Fetzer, U. and Laufen, H. (1992) Eur. Arch. Psychiatry Clin. Neurosci., 242(2-3), 96-102.
61. Millefiorini, E.; Gasperini, C.; Pozzilli, C.; D'Andrea, F.; Bastianello, S.; Trujano, M.; Morino, S.; Morra, V.B.; Bozzao, A.; Calo A.; Bernini M.L.; Gambi, D. and Prencipe, M. (1997) J. Neurol., 244(3), 153-159.
62. Hartung, H.P.; Gonsette, R.; Konig, N.; Kwiecinski, H.; Guseo, A.; Morrissey, S.P.; Krapf H.; Zwingers, T. and Mitoxantrone in Multiple Sclerosis Study Group (MIMS) (2002) Lancet, 360(9350), 2018-2025.
63. Bruce, A. Cohen and Daniel, Mikol, D. (2004) Neurology, 63, S28-32.
64. Sellebjerg, F.; Frederiksen, J.L.; Nielsen, P.M. and Olesen, J. (1998) Neurology, 51(2), 529-534.
65. Sharrack, B.; Hughes, RA.; Morris, R.W.; Soudain, S.; Wade-Jones, O.; Barnes, D.; Brown, P.; Britton, T.; Francis, D.A.; Perkin, G.D.; Rudge, P.; Swash, M.; Katifi, H.A.; Farmer, S. and Frankel, J.P. (2000) J. Neurol. Sci., 173(1), 73-77.
66. Cazzato, G.; Mesiano, T.; Antonello, R.; Monti, F.; Carraro, N.; Torre, P.; Bosco, A. and Cargnelutti, D. (1995) Eur. Neurol., 35(4), 193-198.
67. Zivadinov, R,.; Rudick, R.A.; De Masi, R.; Nasuelli, D.; Ukmar, M.; Pozzi-Mucelli, R.S.; Grop, A.; Cazzato, G. and Zorzon, M. (2001) Neurology, 57(7), 1239-1247.
68. de Seze, J.; Chapelotte, M.; Dufour-Delalande, S.; ferriby, D.; Stojkovic, T. and Vermersch, P. (2004) Mult. Scler., 10(5), 596-597.
69. Hauser, S.L.; Dawson, D.M.; Lehrich, J.R.; Beal, M.F.; Kevy, S.V.; Propper, R.D.; Mills, JA. and Weiner, H.L. (1983) N. Engl. J. Med., 308(4), 173-180.
70. The Canadian Cooperative Multiple Sclerosis Study Group. (1991) Lancet, 337, 441-446.
71. Likosky, W.H.; Fireman, B.; Elmore, R.; Eno, G.; Gale, K.; Goode, G.B.; Ikeda, K.; Laster, J.; Mosher, C. and Rozance, J. (1991) J. Neurol. Neurosurg. Psychiatry, 54(12), 1055-1060.
72. LaMantia, L.; Milanese, C.; Mascoli, N.; D'Amico, R. and Weinstock-Guttman, B. (2007) Cochrane Database Syst. Rev., 4, CD002819.
73. Reggio, E.; Nicoletti, A.; Fiorella, T.; Politi, G.; Reggio, A. and Patti, F. (2005) J. Neurol., 252(10), 1255-1261.
74. Smith, D. (2004) J. Neurol. Sci., 223, 73-79.
75. Weiner, H.L. and Cohen, J.A. (2002) Mult. Scler., 8(2), 142-154.
76. Yudkin, P.L.; Ellison, G.W.; Ghezzi, A.; Goodkin, D.E.; Hughs, R.A.; McPherson, K.; Mertin, J. and Milanese, C. (1991) Lancet, 338(8774), 1051-1055.
77. Fernandez, O.; Guerrero, M.; Mayorga, C.; Munoz, L.; Lean, A.; Luque, G.; Hervas, M.; Fernandez V.; Capdevila, A. and de Ramon, E. (2002) J. Neurol., 249(8), 1058-1062.
78. Lus, Q.; Romano, F.; Scuotto, A.; Accardo, C. and Cotrufo, R. (2004) Eur. Neurol., 51, 15-20.
79. Pulicken, M.; Bash, C.N.; Costello, K.; Said, A.; Cuffari, C.; Wilterdink, J.L.; Rugg, J.M.; Mills, P. and Calabresi, P.A. (2005) Mult. Scler., 11(2), 169-174.
80. Calabresi, P.A.; Wilterdink, J.L.; Rogg, J.M.; Mills, P.; Webb, A. and Whartenby, K.A. (2002) Neurology, 58(2), 314-317.
81. Sorensen, P.S. (2003) J. Neurol. Sci., 206(2), 123-130.
82. Trebst, C. and Stangel, M. (2006) Curr. Pharm. Des., 12(2), 241-249.
83. Sorensen, P.S., Fazekas, F. and Lee, M. (2002) Eur. J. Neurol., 9(6), 557-563.
84. Achiron, A.; Kishner, I.; Doley, M.; Dulitzky, M.; Schiff, E. and Achiron, R.(2004) J. Neurol., 251(9), 1133-1137.
85. Weinshenker, B.G.; O'Brien, P.C.; Petterson, T.M.; Noseworthy, J.H.; Lucchinetti, C.F.; Dodick, D.W.; Pineda, A.A.; Stevens, L.N. and Rodriguez, M. (1999) Ann. Neurol., 46(6), 878-886.
86. Kappos, L.; Antel, J.; Comi, G.; Montablan, X.; O'Conner, P.; Polman, C.H.; Haas, T.; Kom, A.A.; Karlsson, G.; Radue, E.W. and FIY720D2201 Study Group (i006) N. Eng. J. Med., 355(11), 1124-1140.
87. Romine, J.S.; Sipe, J.C.; Koziol, J.A.; Zyroff, J. and Beutler, E. (1999) Proc. Assoc. Am. Phys., 111(1), 35-44.
88. Rice, G.P.; Filippi, M. and Comi, G. (2000) Neurology, 54(5), 1145-1155.
89. Vollmer, T.; Key, L.; Durkalski, V.; Tyor, W.; Corboy, J.; Markovic-Plese, S.; Preiningerova, J.; Rizzo, M. and Singh, I. (2004) Lancet, 363(9421), 1607-1608.
90. Sicotte, N.L.; Liva, S.M.; Klutch, R.; Pfeiffer, P.; Bourier, S.; Odesa, S.; Wu, T.C. and Voskuhl, R.R. (2002) Ann. Neurol., 52, 421-42.
91. Vermersch, P.; Waucquier, N.; Michelin, E.; Bourteel, H.; Stojkovic, T.; Ferriby, D. and De Seze, J. (2007) Eur. J. Neurol., 14(1), 85-89.
92. Guiliani, F.; Fu, S.A.; Metz, L.M. and Yong, V.W. (2005) J. Neuroimmunol., 165(1-2), 83-91.
93. Milligan, N.M. and Compston, D.S. (1994) J. Neurol. Neurosurg. Psychiatry, 57, 164-168.
94. Noseworthy, J.H.; Wolinsky, J.S.; Lublin, F.D.; Whitaker, J.N.; Linde, A.; Gjorstrup, P. and Sullivan, H.C. (2000) Neurology, 54(9), 1726-1733.
95. Panitch, H.S.; Hirsh, R.I.; Schindler, J. and Johnson, K.P. (1987) Neurology, 37(7), 1097-1102:
96. Camenga, D.L.; Johnson, K.P.; Alter, M.; Engelhardt, iC.D.; Fishman, P.S.; Greenstein, J.I.; Haley, A.S.; Hirsch, R.L.; Kleiner, J.E.; Kofie, V.Y. et al. (1986) Arch. Neurol., 43(12), 1239-1246.
97. AUSTIMS Reseatch Group. (1989) J. Neurol. Neurosurg. Psychiatry, 52, 566-574.
98. Multiple Sclerosis Study Group. (1990) Ann. Neurol., 27, 591-605.
99. Noseworthy, J.H.; O'Brien, P. and the Mayo Clinic-Canadian Cooperative Study Group (1998) Neurology, 51(5), 1342-1152.
100. Weinshenker, B.G.; Bass, B.; Karlik, S.; Ebers, G.C. and Rice, G.P.A. (1991) Neurology, 41(7), 1047-1052.
101. Lenercept Multiple Sclerosis Study Group and The University of Britsh Columbia. (1999) Neurology, 53, 457-465.